In several mass screening studies conducted in Wuzhou and Cangwu, China [42]–[45], Zeng et al. reported that the NPC annual incidence rate for VCA/IgA(+) persons was 2-fold to 81-fold the rate in age-group-matched general population. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.